Thomson CenterWatch recently launched a content management service to assist sponsors in complying with the latest requirements for clinical trial transparency. This web based program serves as a tool for sponsors to register their active clinical trials and publish their clinical trial results while following the data field guidelines established by clinicaltrials.gov and the World Health Organization and ICMJE.
Thomson CenterWatch recently launched a content management service to assist sponsors in complying with the latest requirements for clinical trial transparency. This web based program serves as a tool for sponsors to register their active clinical trials and publish their clinical trial results while following the data field guidelines established by clinicaltrials.gov and ICMJEthe World Health Organization and ICMJE.
Using the latest and most secure web-enabled technology, sponsors can efficiently create, manage and publish their clinical trial information from anywhere. Thomson CenterWatch serves as the central repository for the trial content and then distributes registry and results information to mandated web sites in accordance with the latest guidelines.
For over a decade, Thomson CenterWatch has been informing patients and health professionals about ongoing clinical trials. Their Clinical Trials Listing Service™ currently contains nearly 20,000 active listings and is integrated within the web sites of over 80 health associations and patient advocacy groups.
Other benefits of Thomson CenterWatch's Registry/Results Service:
› Accessibility: WebMD, the Discovery Health Channel, Washington Post, Newsweek,PDR.net and thousands of other web sites and feature Thomson CenterWatch clinical trials content
› Compliance:Thomson CenterWatch keeps current with disclosure issues and updates
› Visibility: Consistently ranks #1 or 2 on all major search engines for clinical trials information, including Google and Yahoo
› Exposure: In 2004, www.centerwatch.com received over 10 million visitors
› Credibility: A business of Thomson Scientific and Healthcare, a division of the Thomson Corporation (NYSE:TOC)
For more information on how Thomson CenterWatch can help you with your clinical trial related needs visit http://www.centerwatch.com or contact David Heck at (513) 754-1705 or [email protected]
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.